The Role of N6-methyladenosine-modified Non-coding RNAs in the Pathological Process of Human Cancer

Overview

Journal Cell Death Discov

Date 2022 Jul 19

PMID 35851061

Authors

Lin Luo

Yingwei Zhen

Dazhao Peng

Cheng Wei

Xiaoyang Zhang

Xianzhi Liu

Lei Han

Zhenyu Zhang

Affiliations

Soon will be listed here.

Abstract

Non-coding RNAs (ncRNAs) account for the majority of the widespread transcripts of mammalian genomes. They rarely encode proteins and peptides, but their regulatory role is crucial in numerous physiological and pathological processes. The m6A (N6-methyladenosine) modification is one of the most common internal RNA modifications in eukaryotes and is associated with all aspects of RNA metabolism. Accumulating researches have indicated a close association between m6A modification and ncRNAs, and suggested m6A-modified ncRNAs played a crucial role in tumor progression. The correlation between m6A modification and ncRNAs offers a novel perspective for investigating the potential mechanisms of cancer pathological processes, which suggests that both m6A modification and ncRNAs are critical prognostic markers and therapeutic targets in numerous malignancies. In the present report, we summarized the interaction between m6A modification and ncRNA, emphasizing how their interaction regulates pathological processes in cancer.

Citing Articles

IGF2BP2 Shapes the Tumor Microenvironment by Regulating Monocyte and Macrophage Recruitment in Bladder Cancer.

Li J, Jiang Y, Ma M, Wang L, Jing M, Yang Z Cancer Med. 2024; 13(24):e70506.

PMID: 39711402 PMC: 11664238. DOI: 10.1002/cam4.70506.

Unlocking the dark matter: noncoding RNAs and RNA modifications in cardiac aging.

Kang J, Rhee J, Wang C, Yang Y, Li G, Li H Am J Physiol Heart Circ Physiol. 2024; 326(3):H832-H844.

PMID: 38305752 PMC: 11221808. DOI: 10.1152/ajpheart.00532.2023.

[Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of  m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of  Lung Cancer].

Zhang Y, Wang Y, Liu M Zhongguo Fei Ai Za Zhi. 2024; 26(12):919-933.

PMID: 38163978 PMC: 10767667. DOI: 10.3779/j.issn.1009-3419.2023.102.45.

Downregulated M6A modification and expression of circRNA_103239 promoted the progression of glioma by regulating the miR-182-5p/MTSS1 signalling pathway.

Zhang S, Zhang P, Wu A, Xu Z, Huang S, Liu X J Cancer. 2023; 14(18):3508-3520.

PMID: 38021156 PMC: 10647192. DOI: 10.7150/jca.85320.

A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma-From mA Modification to Blood Biomarkers.

Eun J, Cheong J, Jeong J, Kim H Cells. 2023; 12(18).

PMID: 37759495 PMC: 10528438. DOI: 10.3390/cells12182272.

References

Li B, Zhu L, Lu C, Wang C, Wang H, Jin H . circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat Commun. 2021; 12(1):295. PMC: 7804955. DOI: 10.1038/s41467-020-20527-z. View

Xu F, Huang X, Li Y, Chen Y, Lin L . mA-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD. Mol Ther Nucleic Acids. 2021; 24:780-791. PMC: 8094594. DOI: 10.1016/j.omtn.2021.04.003. View

Wojtas M, Pandey R, Mendel M, Homolka D, Sachidanandam R, Pillai R . Regulation of mA Transcripts by the 3'→5' RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline. Mol Cell. 2017; 68(2):374-387.e12. DOI: 10.1016/j.molcel.2017.09.021. View

Knuckles P, Lence T, Haussmann I, Jacob D, Kreim N, Carl S . Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the mA machinery component Wtap/Fl(2)d. Genes Dev. 2018; 32(5-6):415-429. PMC: 5900714. DOI: 10.1101/gad.309146.117. View

Ma Y, Hong Y, Yu G, Jiang S, Zhao B, Guo A . LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance. Cancer Cell Int. 2021; 21(1):501. PMC: 8449476. DOI: 10.1186/s12935-021-02209-y. View

Rong D, Dong Q, Qu H, Deng X, Gao F, Li Q . mA-induced LINC00958 promotes breast cancer tumorigenesis via the miR-378a-3p/YY1 axis. Cell Death Discov. 2021; 7(1):27. PMC: 7854648. DOI: 10.1038/s41420-020-00382-z. View

Zhou K, Pan T . An additional class of mA readers. Nat Cell Biol. 2018; 20(3):230-232. PMC: 5831501. DOI: 10.1038/s41556-018-0046-y. View

Zeng H, Xu Y, Xu S, Jin L, Shen Y, Rajan K . Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs. Front Cell Dev Biol. 2021; 9:698388. PMC: 8417314. DOI: 10.3389/fcell.2021.698388. View

Ye X, Wang L, Han C, Hu H, Ni C, Qiao G . Increased mA modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163/USP44 axis. Ann Transl Med. 2022; 10(6):304. PMC: 9011309. DOI: 10.21037/atm-22-556. View

10.

Hsu P, Zhu Y, Ma H, Guo Y, Shi X, Liu Y . Ythdc2 is an N-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 2017; 27(9):1115-1127. PMC: 5587856. DOI: 10.1038/cr.2017.99. View

11.

Linder B, Grozhik A, Olarerin-George A, Meydan C, Mason C, Jaffrey S . Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. Nat Methods. 2015; 12(8):767-72. PMC: 4487409. DOI: 10.1038/nmeth.3453. View

12.

Cai J, Chen Z, Zhang Y, Wang J, Zhang Z, Wu J . CircRHBDD1 augments metabolic rewiring and restricts immunotherapy efficacy via mA modification in hepatocellular carcinoma. Mol Ther Oncolytics. 2022; 24:755-771. PMC: 8908059. DOI: 10.1016/j.omto.2022.02.021. View

13.

Meyer K . DART-seq: an antibody-free method for global mA detection. Nat Methods. 2019; 16(12):1275-1280. PMC: 6884681. DOI: 10.1038/s41592-019-0570-0. View

14.

Zhang Z, Chen L, Zhao Y, Yang C, Roundtree I, Zhang Z . Single-base mapping of mA by an antibody-independent method. Sci Adv. 2019; 5(7):eaax0250. PMC: 6609220. DOI: 10.1126/sciadv.aax0250. View

15.

Gu L, Wang L, Chen H, Hong J, Shen Z, Dhall A . CG14906 (mettl4) mediates mA methylation of U2 snRNA in . Cell Discov. 2020; 6:44. PMC: 7324582. DOI: 10.1038/s41421-020-0178-7. View

16.

Li A, Chen Y, Ping X, Yang X, Xiao W, Yang Y . Cytoplasmic mA reader YTHDF3 promotes mRNA translation. Cell Res. 2017; 27(3):444-447. PMC: 5339832. DOI: 10.1038/cr.2017.10. View

17.

Ashwal-Fluss R, Meyer M, Pamudurti N, Ivanov A, Bartok O, Hanan M . circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014; 56(1):55-66. DOI: 10.1016/j.molcel.2014.08.019. View

18.

Rong B, Zhang Q, Wan J, Xing S, Dai R, Li Y . Ribosome 18S mA Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth. Cell Rep. 2020; 33(12):108544. DOI: 10.1016/j.celrep.2020.108544. View

19.

Huang H, Weng H, Chen J . mA Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer. Cancer Cell. 2020; 37(3):270-288. PMC: 7141420. DOI: 10.1016/j.ccell.2020.02.004. View

20.

Wang P, Doxtader K, Nam Y . Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases. Mol Cell. 2016; 63(2):306-317. PMC: 4958592. DOI: 10.1016/j.molcel.2016.05.041. View